M&A

Magnifying glass focusing on number 2026 with target icon on yellow background

Biotech

Despite headwinds, biotech industry charges forward behind M&A

Biotech’s effervescent activity has allowed it to overcome headwinds and sustain momentum, as the volume and value of M&A deals continue to increase.

Kevin Dunleavy Jun 9, 2026 12:41pm

Concepts of medical examination and study of intestine microflora

Galmed buys Colospan in $4.5M deal as it eyes $6B GI dx market

Jun 9, 2026 8:01am

The abstract concept of teamwork partnership merger alliance

ResMed snaps up Noctrix Health in $340M sleep tech deal

Jun 8, 2026 10:47am

Ultrasound

Endologix acquires thrombectomy system from Surmodics

May 20, 2026 8:01am

helicopter rescue mission save aircraft

Cash-strapped Quince finds salvation in reverse merger

May 18, 2026 10:32am

Roche

Roche shells out up to $1B for PathAI to boost AI diagnostics

May 7, 2026 9:30am